Skip to main content
Erschienen in: Clinical Rheumatology 6/2015

01.06.2015 | Original Article

Clinical features and types of articular involvement in patients with psoriatic arthritis

verfasst von: Salim Dönmez, Ömer Nuri Pamuk, Mustafa Akker, Recep Ak

Erschienen in: Clinical Rheumatology | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Psoriatic arthritis (PsA) is a psoriasis-associated inflammatory arthritis which causes joint destruction. There are some epidemiologic data about PsA; however, there are no sufficient data from Turkey. Herein, we evaluated the frequency of PsA in the Thrace region of Turkey according to hospital-based data. In addition, we evaluated clinical features and types of joint involvement in PsA patients. We included 172 PsA patients fulfilling CASPAR criteria admitted to the Division of Rheumatology, Trakya University Medical Faculty, between 2003 and 2012. Data from Turkish Statistical Institution was used to calculate the incidence and prevalence of PsA. Patients’ demographic features, durations of psoriasis and PsA, number of tender and swollen joints, treatment modalities, laboratory data, and X-ray film findings were recorded from hospital files. The annual incidence of PsA was 2.8/100,000. The mean annual incidence was 3.47/100,000 in females and 2.15/100,000 in males. The overall prevalence of PsA in our region was 27.9/100,000 (95 % confidence interval (CI) 23.7–32.1) in individuals >16 years. The prevalence of PsA was higher in females than in males (34.7/100,000 vs. 21.5/100,000). Polyarthritis was present in 67 (38.9 %), oligoarthritis in 47 (27.3 %), spondyloarthritis in 39 (22.6 %), and distal interphalangeal (DIP) arthritis in 19 (11.0 %) patients. The duration of psoriasis was significantly longer in polyarticular PsA patients than in DIP and oligoarticular groups (p values = 0.016 and 0.018, respectively). The number of swollen joints correlated with age (r = 0.21, p = 0.006), duration of psoriasis (r = 0.20, p = 0.01), number of tender joints (r = 0.92, p ≤ 0.001), ESR (r = 0.24, p = 0.001), and CRP (r = 0.17, p = 0.026). The frequency of PsA in Thrace region is similar to that in low-frequency regions. The most frequent type of involvement was polyarticular, and it correlated with the duration of psoriasis and erosive disease.
Literatur
1.
Zurück zum Zitat Duarte GV, Faillace C, Freire de Carvalho J (2012) Psoriatic arthritis. Best Pract Res Clin Rheumatol 26:147–156CrossRefPubMed Duarte GV, Faillace C, Freire de Carvalho J (2012) Psoriatic arthritis. Best Pract Res Clin Rheumatol 26:147–156CrossRefPubMed
2.
Zurück zum Zitat Cantini F, Niccoli L, Nannini C, Kaloudi O, Bertoni M, Cassarà E (2010) Psoriatic arthritis: a systematic review. Int J Rheum Dis 13:300–317CrossRefPubMed Cantini F, Niccoli L, Nannini C, Kaloudi O, Bertoni M, Cassarà E (2010) Psoriatic arthritis: a systematic review. Int J Rheum Dis 13:300–317CrossRefPubMed
3.
Zurück zum Zitat Sadek HA, Abdel-Nasser AM, El-Amawy TA, Hassan SZ (2007) Rheumatic manifestations of psoriasis. Clin Rheumatol 26:488–498CrossRefPubMed Sadek HA, Abdel-Nasser AM, El-Amawy TA, Hassan SZ (2007) Rheumatic manifestations of psoriasis. Clin Rheumatol 26:488–498CrossRefPubMed
4.
Zurück zum Zitat Prey S, Paul C, Bronsard V, Puzenat E, Gourraud PA, Aractingi S et al (2010) Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature. J Eur Acad Dermatol Venereol 24(Suppl 2):31–35CrossRefPubMed Prey S, Paul C, Bronsard V, Puzenat E, Gourraud PA, Aractingi S et al (2010) Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature. J Eur Acad Dermatol Venereol 24(Suppl 2):31–35CrossRefPubMed
5.
Zurück zum Zitat Onumah N, Kircik LH (2012) Psoriasis and its comorbidities. J Drugs Dermatol 11(5 Suppl):s5–s10PubMed Onumah N, Kircik LH (2012) Psoriasis and its comorbidities. J Drugs Dermatol 11(5 Suppl):s5–s10PubMed
6.
Zurück zum Zitat Alamanos Y, Voulgari PV, Drosos AA (2008) Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol 35:1354–1358PubMed Alamanos Y, Voulgari PV, Drosos AA (2008) Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol 35:1354–1358PubMed
7.
Zurück zum Zitat Salvarani C, Lo Scocco G, Macchioni P, Cremonesi T, Rossi F, Mantovani W et al (1995) Prevalence of psoriatic arthritis in Italian psoriatic patients. J Rheumatol 22:1499–1503PubMed Salvarani C, Lo Scocco G, Macchioni P, Cremonesi T, Rossi F, Mantovani W et al (1995) Prevalence of psoriatic arthritis in Italian psoriatic patients. J Rheumatol 22:1499–1503PubMed
8.
Zurück zum Zitat Salvarani C, Olivieri I, Cantini F, Macchioni L, Boiardi L (1998) Psoriatic arthritis. Curr Opin Rheumatol 10:299–305CrossRefPubMed Salvarani C, Olivieri I, Cantini F, Macchioni L, Boiardi L (1998) Psoriatic arthritis. Curr Opin Rheumatol 10:299–305CrossRefPubMed
9.
Zurück zum Zitat Kaipiaine S (1996) Incidence of psoriatic arthritis in Finland. Br J Rheumatol 35:1289–1291CrossRef Kaipiaine S (1996) Incidence of psoriatic arthritis in Finland. Br J Rheumatol 35:1289–1291CrossRef
10.
Zurück zum Zitat Mathieu A, Cauli A, Vacca A, Mameli A, Passiu G, Porru G et al (2007) Genetics of psoriasis and psoriatic arthritis. Reumatismo 59(Suppl 1):25–27PubMed Mathieu A, Cauli A, Vacca A, Mameli A, Passiu G, Porru G et al (2007) Genetics of psoriasis and psoriatic arthritis. Reumatismo 59(Suppl 1):25–27PubMed
11.
Zurück zum Zitat Creamer D, Jaggar R, Allen M, Bicknell R, Barker J (1997) Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis. Br J Dermatol 137:851–855CrossRefPubMed Creamer D, Jaggar R, Allen M, Bicknell R, Barker J (1997) Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis. Br J Dermatol 137:851–855CrossRefPubMed
12.
Zurück zum Zitat Cakir N, Pamuk ON, Dervis E, Imeryüz N, Uslu H, Benian Ö et al (2012) The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int 32:895–908CrossRefPubMed Cakir N, Pamuk ON, Dervis E, Imeryüz N, Uslu H, Benian Ö et al (2012) The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int 32:895–908CrossRefPubMed
13.
Zurück zum Zitat Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673CrossRefPubMed Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673CrossRefPubMed
14.
Zurück zum Zitat Ogdie A, Langan S, Love T, Haynes K, Shin D, Seminara N et al (2013) Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford) 52:568–575CrossRef Ogdie A, Langan S, Love T, Haynes K, Shin D, Seminara N et al (2013) Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford) 52:568–575CrossRef
15.
Zurück zum Zitat Silman AJ (2001) Psoriatic arthropathy. In: Silman AJ, Hochberg MC (eds) Epidemiology of the rheumatic diseases, 2nd edn, pp 85–99 Silman AJ (2001) Psoriatic arthropathy. In: Silman AJ, Hochberg MC (eds) Epidemiology of the rheumatic diseases, 2nd edn, pp 85–99
16.
17.
Zurück zum Zitat Madland TM, Apalset EM, Johannesen AE, Rossebo B, Brun JG (2005) Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol 32:1918–1922PubMed Madland TM, Apalset EM, Johannesen AE, Rossebo B, Brun JG (2005) Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol 32:1918–1922PubMed
18.
Zurück zum Zitat Alamanos Y, Papadopoulos NK, Voulgari PV, Siozos C, Psychos DN, Tympanidou M et al (2003) Epidemiology of psoriatic arthritis in Northwest Greece, 1982–2001. J Rheumatol 30:2641–2644PubMed Alamanos Y, Papadopoulos NK, Voulgari PV, Siozos C, Psychos DN, Tympanidou M et al (2003) Epidemiology of psoriatic arthritis in Northwest Greece, 1982–2001. J Rheumatol 30:2641–2644PubMed
20.
Zurück zum Zitat Gunal EK, Kamali S, Gul A, Ocal L, Konice M, Aral O et al (2009) Clinical evaluation and comparison of different criteria for classification in Turkish patients with psoriatic arthritis. Rheumatol Int 29:365–370CrossRefPubMed Gunal EK, Kamali S, Gul A, Ocal L, Konice M, Aral O et al (2009) Clinical evaluation and comparison of different criteria for classification in Turkish patients with psoriatic arthritis. Rheumatol Int 29:365–370CrossRefPubMed
21.
Zurück zum Zitat Nossent JC, Gran JT (2009) Epidemiological and clinical characteristics of psoriatic arthritis in Northern Norway. Scand J Rheumatol 38:251–255CrossRefPubMed Nossent JC, Gran JT (2009) Epidemiological and clinical characteristics of psoriatic arthritis in Northern Norway. Scand J Rheumatol 38:251–255CrossRefPubMed
22.
Zurück zum Zitat Soriano ER, Rosa J, Velozo E, Schpilberg M, Imamura PM, Diaz J et al (2011) Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study. Rheumatology (Oxford) 50:729–734CrossRef Soriano ER, Rosa J, Velozo E, Schpilberg M, Imamura PM, Diaz J et al (2011) Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study. Rheumatology (Oxford) 50:729–734CrossRef
23.
Zurück zum Zitat Maejima H, Taniguchi T, Watarai A, Aki R, Katsuoka K (2010) Analysis of clinical, radiological and laboratory variables in psoriatic arthritis with 25 Japanese patients. J Dermatol 37:647–656CrossRefPubMed Maejima H, Taniguchi T, Watarai A, Aki R, Katsuoka K (2010) Analysis of clinical, radiological and laboratory variables in psoriatic arthritis with 25 Japanese patients. J Dermatol 37:647–656CrossRefPubMed
24.
Zurück zum Zitat Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK (1987) Psoriatic arthritis (PSA)—an analysis of 220 patients. Q J Med 62:127–141PubMed Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK (1987) Psoriatic arthritis (PSA)—an analysis of 220 patients. Q J Med 62:127–141PubMed
25.
Zurück zum Zitat Inanc N, Dalkilic E, Kamali S, Kasapoglu-Günal E, Elbir Y, Direskeneli H et al (2007) Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis. Clin Rheumatol 26:17–23CrossRefPubMed Inanc N, Dalkilic E, Kamali S, Kasapoglu-Günal E, Elbir Y, Direskeneli H et al (2007) Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis. Clin Rheumatol 26:17–23CrossRefPubMed
26.
Zurück zum Zitat McGonagle D, Gibbon W, Emery P (1998) Classification of inflammatory arthritis by enthesitis. Lancet 352:1137–1140CrossRefPubMed McGonagle D, Gibbon W, Emery P (1998) Classification of inflammatory arthritis by enthesitis. Lancet 352:1137–1140CrossRefPubMed
27.
Zurück zum Zitat Chandran V, Schentag CT, Gladman DD (2007) Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 57:1560–1563CrossRefPubMed Chandran V, Schentag CT, Gladman DD (2007) Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 57:1560–1563CrossRefPubMed
28.
Zurück zum Zitat Helliwell PS, Porter G, Taylor WJ (2007) Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis 66:113–117CrossRefPubMedCentralPubMed Helliwell PS, Porter G, Taylor WJ (2007) Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis 66:113–117CrossRefPubMedCentralPubMed
Metadaten
Titel
Clinical features and types of articular involvement in patients with psoriatic arthritis
verfasst von
Salim Dönmez
Ömer Nuri Pamuk
Mustafa Akker
Recep Ak
Publikationsdatum
01.06.2015
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 6/2015
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2746-4

Weitere Artikel der Ausgabe 6/2015

Clinical Rheumatology 6/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.